Doctor Michaella Goldstein
Email to Doctor Goldstein
michaella_goldstein@topichilov.com
Ophthalmologist with over 25 years of work experience, Head of Retinal Disease Department of the Ichilov Medical Center. Was awarded with the title of the best physician in this medical center.
English
Hebrew
Tel Aviv State University (Israel), lecturer at Ophthalmology Department
Head of the Department of Retina and Vitreous Diseases, Ichilov-Sourasky Medical Center
Private practice at the Top Ichilov Clinic
Deputy Head of Ophthalmology Department, Ichilov-Sourasky Medical Center
Senior physician of Ophthalmology Department, Ichilov Medical Center
Physician of Ophthalmology Department, Ichilov-Sourasky Medical Center
Ophthalmologist in the military base for recruitment and military training, Israel Defense Forces
Moorfields Eye Hospital in London (England), specialization in retinal diseases
Ichilov-Sourasky Medical Center, specialization in ophthalmology
Beilinson Clinic (Israel), specialization in ophthalmology
Tel Aviv State University, specialization in ophthalmology
Tel Aviv State University, Faculty of Medicine
Association for Research in Vision and Ophthalmology (ARVO)
Israel Ophthalmology Society
Israel Society for Vision and Eye Research
Doctor Goldstein is an experienced Israeli ophthalmologist, expert in treatment of retinal diseases including diabetic retinopathy.
“Age-related macular degeneration is a condition that progresses throughout life. As a rule, it is detected in people over 50. Many patients pay no attention to the vision loss until they are 60 or 70. In 10-15% of cases, we detect the so-called wet macular degeneration. Without treatment, this condition leads to persistent vision loss.
About 10 years ago, we developed a new treatment method. This method implies injecting medicine directly into the eye. Historically, patients were recommended conventional monthly injections.
Today, we can use an advanced technology called optical coherence tomography, or OCT. It helps determine whether the medicine is effective. If required, we can change the dosage and personalize the therapy because some patients simply do not need monthly intraocular injections. Therefore, OCT and inexpensive injected medications helps us develop personalized treatment plans for our patients.”
Was celebrated by the independent “Dun & Bradstreet Israel” audit company as one of the leading specialists in her field and included into the rating of 194 best ophthalmologists, cardiologists and surgeons of the country.
Publications in Foreign Medical Journals:
Complete list (38):
https://www.ncbi.nlm.nih.gov/pubmed?term=Goldstein%2C%20Michaella[Full%20Author%20Name]
Author’s Name: Dmitry Finkelstein